Login / Signup

A randomized, double-blind, placebo-controlled, repeated-dose pilot study of the safety, tolerability, and preliminary effects of a cannabidiol (CBD)- and cannabigerol (CBG)-based beverage powder to support recovery from delayed onset muscle soreness (DOMS).

Erica N PetersHelena YardleyAmy HarrisonGraham M L EglitJose AntonioCynthia TurcotteMarcel O Bonn-Miller
Published in: Journal of the International Society of Sports Nutrition (2023)
The tested formulation reduced interference of DOMS on daily activities, demonstrating its improvement on a functional aspect of recovery.
Keyphrases
  • placebo controlled
  • double blind
  • phase ii
  • phase iii
  • clinical trial
  • study protocol
  • phase ii study
  • drug delivery
  • skeletal muscle
  • physical activity
  • open label
  • randomized controlled trial